Fifth Third Bancorp’s Rocket Pharmaceuticals RCKT Stock Holding History

Fifth Third Bancorp’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$661	Sell	193 -80	-29%	-$266	﹤0.01%	4208
2026 Q1	$977	Buy	+273	New	+$1.08K	﹤0.01%	4131
2022 Q3	–	Sell	-103	Closed	-$1K	–	2729
2022 Q2	$1K	Sell	103 -20	-16%	-$238	﹤0.01%	2570
2022 Q1	$2K	Buy	123 +75	+156%	+$1.3K	﹤0.01%	2547
2021 Q4	$1K	Buy	48 +9	+23%	+$246	﹤0.01%	2632
2021 Q3	$1K	Hold	39	–	–	﹤0.01%	2596
2021 Q2	$2K	Buy	39 +12	+44%	+$521	﹤0.01%	2350
2021 Q1	$1K	Buy	27 +11	+69%	+$604	﹤0.01%	2374
2020 Q4	$1K	Buy	+16	New	+$583	﹤0.01%	2300
2018 Q1	–	Sell	-500	Closed	-$5K	–	2380
2017 Q4	$5K	Buy	+500	New	+$4.96K	﹤0.01%	2001

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fifth Third Bancorp's RCKT Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Rocket Pharmaceuticals (RCKT) stake by 29% in Q2 2026, selling an estimated $266 and leaving 193 shares worth $661. The position accounts for ﹤0.01% of the portfolio, ranked #4208.

Fifth Third Bancorp first reported a position in RCKT in Q4 2017 and has held it in 10 quarters since. The position peaked at $5K in Q4 2017. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Fifth Third Bancorp held 193 shares of Rocket Pharmaceuticals worth $661 as of Q2 2026.
Fifth Third Bancorp sold 80 Rocket Pharmaceuticals shares in Q2 2026, an estimated $266.
Rocket Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4208 holding.
Fifth Third Bancorp first reported a position in Rocket Pharmaceuticals in Q4 2017 and has held it in 10 quarters since.
Fifth Third Bancorp's Rocket Pharmaceuticals position peaked at $5K in Q4 2017.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.